MedPath

effect of hesperidin on depressio

Phase 3
Recruiting
Conditions
Major Depressive Disorder.
Major depressive disorder, single episode, severe with psychotic features
Registration Number
IRCT20090901002394N40
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Willing to participate
Clinical diagnosis of major depressive disorder; A score =15 in the 17-item Hamilton Depression Rating Scale;
Age 18 – 65 years;
Good health status based on medical history
No dietary supplement use during the previous two months
No antidepressant or steroid use
Absence of benign hormone-sensitive tumors in the ovary, uterus, breast, prostate
Not having thoughts about death and suicide
Not having any mental illness except anxiety
Do not eat citrus more than two units per day

Exclusion Criteria

Pregnancy and lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum level of cortisol. Timepoint: beginning and end of intervention. Method of measurement: ELIZA.;Serum level of homocysteine. Timepoint: beginning and end of intervention. Method of measurement: ELIZA.;Serum level of tryptophan. Timepoint: beginning and end of intervention. Method of measurement: ELIZA.;Serum level of kynurenine. Timepoint: beginning and end of intervention. Method of measurement: ELIZA.
Secondary Outcome Measures
NameTimeMethod
Physical activity. Timepoint: beginning and end of intervention. Method of measurement: IPAQ questionnaire.;Energy intake. Timepoint: beginning and end of intervention. Method of measurement: Three-day food record.
© Copyright 2025. All Rights Reserved by MedPath